Stock Price
3.96
Daily Change
0.04 1.02%
Monthly
-15.02%
Yearly
76.00%
Q1 Forecast
3.82

EDAP TMS reported EUR18.8M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AngioDynamics USD 81.98M 1.96M Feb/2025
Boston Scientific USD 4.04B 18M Dec/2025
EDAP TMS EUR 18.8M 3.01M Sep/2025
Henry Schein USD 3.25B 110M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Veracyte USD 116M 7.24M Dec/2025